Increasing popularity of NHS managed services drives Genmed’s commercial growth

Published: 28-Sep-2017

Genmed announced a strong performance for its financial year ending 31 March 2017, with the business now opening bigger offices in Wales to support ongoing growth as the NHS experiences increasing popularity and adoption of vendor neutral managed services

As a result of this strong performance, Genmed will hire 50% more staff to ensure quality of service for its broad range of NHS Trust and Health Board customers.

Business highlights

  • revenues increased 54% to £32.4 million with earnings before interest, tax, depreciation and amortisation rising 3.46 times to £415,000
  • new investment in larger offices in Cwmbran, Wales will accommodate double the staff.

Customer highlights

  • Genmed now works for 40 NHS Trusts and Health Boards throughout the UK including London North West Healthcare, Norfolk & Norwich University Hospitals and South West London Orthopaedic Elective Care.
  • acting as an extension to a Trust’s procurement department, Genmed so far has worked on 59 contracts in 2017 for approved suppliers to provide equipment and consumables
  • Genmed works with between 500-600 suppliers to the NHS and in total, now has 220 contracts supporting a variety of clinical disciplines such as pathology, surgery, endoscopy, imaging along with medical records, IT and facilities.

Keith Davis, Genmed’s COO, said: “The ability to choose the optimal supplier mix combined with a track record of delivering HMRC compliant contracts has seen our revenues rise to £32.4m in just 10 years trading. The lack of capital resources in the NHS together with the need to reduce revenue costs year on year has led hospitals to seek providers who can generate both economic and efficiency gains. Genmed has demonstrable ability to deliver both.”

Offering a consultative and holistic approach, taking into account patient pathways and the broader impact of how specific procurement can impact care provided and the cost, Genmed creates bespoke HMRC compliant managed service agreements to meet the needs of each Trust.

The use of Genmed in the procurement function helps Trusts to reduce costs, rationalise pricing, improve efficiency, enhance clinical productivity, speed up purchasing, minimise administration and invoice processing and ultimately achieve what appears mutually exclusive — doing more with less.

Genmed’s approach since start up is closely aligned with all the key directives highlighted by Lord Carter of Coles in his report to improve the efficiency of hospitals.

Importantly, Genmed is not tied to any third-party supplier and selects consumables and equipment based on close collaboration and input from NHS managers and clinicians. Genmed is therefore unique in the market to offer flexible vendor neutral managed services. This also means Trusts get the very best value for money which is important given the NHS is publicly funded and budget must be spent effectively and transparently.

Genmed’s managed services package all costs using an umbrella contract with the service then billed monthly or quarterly. All project costs are smoothed with no big upfront investment required.

Genmed is not a managed equipment provider or a finance house. Its remit is much wider. It is an integral partner working with Trusts to ascertain what clinical facilities or technology they need, their workload issues, finding and selecting suppliers, driving product costs down, putting together the finance, managing the contracts, paying subcontractors and taking all the risk upfront itself.

Genmed has developed from its early focus primarily delivering pathology contracts to now manage contracts which encompass surgery, pathology, flexible endoscopy, IT, radiology, electronic data management and renal. It is able to provide sub-PFI building contracts including finance.

Moving forward, the formation of strategic partnerships and the recruitment of specialist staff will enable Genmed to greatly increase its support of Trusts’ clinical services.

Robin Modak, Genmed’s CEO, said: “Our financial performance this year is an endorsement of the tremendous confidence Trusts have in us to manage their businesses. Over and above VAT recovery which gives Trusts a 20% budget boost, we add value in line with Carter’s recommendations about standardising and rationalising the purchase of equipment and consumables and delivering pricing efficiencies.”

You may also like